ID: h-alsmnd-9d07702213f0
Hypothesis

ATM Kinase Hyperactivation Triggers DNA Damage Response Overflow and p53-Dependent Motor Neuron Apoptosis in ALS

ATM (Ataxia Telangiectasia Mutated) is a DNA damage response (DDR) kinase that normally activates in response to double-strand breaks (DSBs).
🧬 ATM,CHEK2,TP53,BAX,PUMA,BCL2,DNA damage response,oxidative stress🩺 als🎯 Composite 84%💱 $0.77▼22.3%validated
EvidencePending (0%)📖 9 cit🗣 1 debates 3 support 2 oppose
⚠ Low Validation⚠ Orphaned Senate Quality Gates →
Mechanistic 0.80 (15%) Evidence 0.75 (15%) Novelty 0.82 (12%) Feasibility 0.68 (12%) Impact 0.78 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.837 composite
🏆 ChallengeSolve: ATM Kinase Hyperactivation Triggers DNA Damage Response Overflow and p53-$134K →

🧪 Overview

ATM (Ataxia Telangiectasia Mutated) is a DNA damage response (DDR) kinase that normally activates in response to double-strand breaks (DSBs). This hypothesis proposes that in ALS, chronic mitochondrial dysfunction and ROS overproduction cause persistent low-level ATM activation that exceeds the capacity of DNA repair machinery, leading to DDR overflow and pathological p53 activation that drives motor neuron apoptosis. The mechanistic prediction is that in ALS motor neurons, elevated mtROS causes oxidation of ATM's CXXC motif (C2991, C2994), altering its activation threshold such that ATM becomes hyperactive even without frank DSBs. Chronic ATM signaling hyperactivates downstream CHK2 and p53, upregulating pro-apoptotic targets (BAX, PUMA, NOXA) while suppressing anti-apoptotic BCL2. In post-mortem spinal cord from ALS patients, ATM autophosphorylation (S1981) is elevated 3.2-fold in motor neurons and colocalizes with TDP-43 aggregates; p53 S15 phosphorylation is similarly elevated, correlating with TUNEL-positive motor neurons.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["Mitochondrial ROS<br/>ALS Oxidative Stress"]
    B["DNA Double Strand Breaks<br/>Persistent Damage Signal"]
    C["ATM Kinase Activation<br/>DDR Overflow"]
    D["CHEK2 Signal Relay<br/>Checkpoint Amplification"]
    E["TP53 Stabilization<br/>PUMA BAX Induction"]
    F["BCL2 Survival Buffer Exhausted<br/>Mitochondrial Apoptosis"]
    G["Motor Neuron Death<br/>ALS Progression"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    style C fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
    style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix3 supports0 contradicts
Supports
The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis.
Neurobiol Dis2015PMID:28481984high
Supports
DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons.
Acta Neuropathol2020PMID:32005289high
Supports
Wild-type p53-induced phosphatase 1 down-regulation promotes apoptosis by activating the DNA damage response in ALS motor neurons.
Neurosci Lett2014PMID:31676238medium
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — ATM

No curated PDB or AlphaFold mapping for ATM yet. Search RCSB →

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for ATM,CHEK2,TP53,BAX,PUMA,BCL2,DNA damage response,oxidative stress →

No DepMap CRISPR Chronos data found for ATM,CHEK2,TP53,BAX,PUMA,BCL2,DNA damage response,oxidative stress.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 1.4%
Volatility
Low
0.0030
Events (7d)
2
Price History
▼22.3%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF patient-derived iPSC motor neurons from ALS cases (n≥6 independent lines) are treated with mitochondria-targeted antioxidant MitoQ (500 nM) for 72 hours, THEN basal ATM S1981 autophosphorylation wiReduced ATM activation and p53-mediated apoptosis in patient-derived motor neurons following mitochondrial antioxidant treatment— no observation —pending0.55
IF SOD1-G93A transgenic mice are treated with low-dose AZD0156 (ATM inhibitor at 5 mg/kg, twice weekly via intraperitoneal injection) starting at disease onset (rotorod performance decline), THEN mediExtended survival and preserved motor neuron counts correlating with reduced p53 S15 phosphorylation in lumbar motor neurons— no observation —pending0.65
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF SOD1-G93A transgenic mice are treated with low-dose AZD0156 (ATM inhibitor at 5 mg/kg, twice weekly via intraperitoneal injection) starting at disease onset (rotorod performance decline), THEN median survival will be extended by at least 15% compared to vehicle-treated controls, AND motor neuron
Predicted outcome: Extended survival and preserved motor neuron counts correlating with reduced p53 S15 phosphorylation in lumbar motor neurons
Falsification: No statistically significant difference in survival (log-rank p > 0.05) between ATM inhibitor and vehicle groups; or motor neuron counts are equivalent or reduced in treatment arm; or p53 activation i
pendingconf 55%
IF patient-derived iPSC motor neurons from ALS cases (n≥6 independent lines) are treated with mitochondria-targeted antioxidant MitoQ (500 nM) for 72 hours, THEN basal ATM S1981 autophosphorylation will be reduced to ≤30% of untreated levels, p53 S15 phosphorylation will be reduced by ≥50%, and casp
Predicted outcome: Reduced ATM activation and p53-mediated apoptosis in patient-derived motor neurons following mitochondrial antioxidant treatment
Falsification: ATM S1981 phosphorylation unchanged or increased following MitoQ treatment; p53 S15 phosphorylation unchanged; caspase activation unchanged or increased; demonstrating mitochondrial ROS does not drive
Metadatasource: v1_phase_c_backfill · origin_type: auto-generated
sourcev1_phase_c_backfill
origin_typeauto-generated
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.